Minimum Titer of ANAs to be Considered Positive

Clinical Significance of Different ANA Titers

• The EULAR/ACR 2019 classification criteria consider an ANA titer of ≥1:80 by indirect immunofluorescence test on HEp-2 cells as positive, with relatively low specificity (74.7%) for systemic lupus erythematosus (SLE) 1, 2
• Titers of ≥1:160 have higher specificity (86.2%) while maintaining adequate sensitivity (95.8%), improving diagnostic performance 3

Diagnostic Algorithm for ANA Interpretation

• Initial screening considers ANA positive at ≥1:80 (EULAR/ACR criteria) 1, 2
• Pattern evaluation identifies specific patterns (homogeneous, speckled, nucleolar, etc.) 4
• Intermediate titers (1:160-1:320) require clinical correlation 4

Special Populations

• In autoimmune hepatitis, ANA titers of >1:80 are considered significant for definite diagnosis, while titers of 1:40 or greater may support a probable diagnosis 5
• Age should be considered in interpretation, as ANA positivity is less common in younger individuals (under 18 years) 3

Common Pitfalls and Caveats

• Different laboratories may use different methods and cutoffs, affecting result interpretation 4
• Positive ANA in asymptomatic individuals should be interpreted cautiously, as up to 70% of initially asymptomatic patients with autoimmune diseases will develop symptoms during the course of their disease 3
• Follow-up testing for specific antibodies (anti-dsDNA, anti-ENA) is recommended for more definitive diagnosis 3, 4